Partisan showdown fails to stop drug advertising ban

Democrats in the Senate moved closer to approving a bill that would ban advertising for a new drug for two years following its approval. Republicans tried and failed at stripping the provision in the PDUFA reauthorization bill. Republicans vowed to continue the fight onto the Senate floor, though, saying that it believed the ban is unconstitutional. Republicans want to replace the ban with new fines for false or misleading advertising. Every five years Congress has to renew PDUFA, which provides hundreds of millions of dollars in industry fees to the FDA while outlining a specific regulatory schedule for drug reviews.

- read the Ad Age report on the legislation

Suggested Articles

Silverback Therapeutics reeled in $85 million to advance its lead antibody-drug conjugate through the clinic and develop its earlier-stage pipeline.

The reported requirements suggest a company is unlikely to have the data needed to support an EUA before the election in six weeks.  

Blocking tau appears to be just as fruitless as clearing amyloid buildup when it comes to helping Alzheimer’s disease patients.